Ignite Creation Date:
2024-06-16 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06441045
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-04
First Post:
2024-05-03
Brief Title:
Double Dose of Third-generation EGFR-TKI Plus Intrathecal Pemetrexed Versus Double Dose of Third-generation EGFR-TKI in Patients With LM Progression Following the Treatment of Routine Dose of Third-generation EGFR-TKI
Sponsor:
Fujian Cancer Hospital
Organization:
Fujian Cancer Hospital
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-10-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2028-04-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-10-01
Completion Date Type:
ESTIMATED
First Submit Date:
2024-05-03
First Submit QC Date:
June 3 2024
Study First Post Date:
2024-06-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-03
Last Update Post Date:
2024-06-04
Last Update Post Date Type:
ACTUAL